Huifang Liu, Sijia Wang, Jing Xin, Jing Wang, Cuiping Yao, Zhenxi Zhang: Role of NKG2D and its ligands in cancer immunotherapy. Am J Cancer Res 2019;9(10):2064-2078. (Full text, PDF)
Chuan Yu, Kevin Hu, Daniel Nguyen, Zhu A Wang: From genomics to functions: preclinical mouse models for understanding oncogenic pathways in prostate cancer. Am J Cancer Res 2019;9(10):2079-2102. (Full text, PDF)
Jun-Cheng Xuhong, Xiao-Wei Qi, Yi Zhang, Jun Jiang: Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. Am J Cancer Res 2019;9(10):2103-2119. (Full text, PDF)
Pei-Ming Yang, Yi-Han Hong, Kai-Cheng Hsu, Tsang-Pai Liu: p38α/S1P/SREBP2 activation by the SAM-competitive EZH2 inhibitor GSK343 limits its anticancer activity but creates a druggable vulnerability in hepatocellular carcinoma. Am J Cancer Res 2019;9(10):2120-2139. (Full text, PDF)
Saisai Wang, Yuanyuan Yao, Xiao Wang, Gang Zheng, Wei Ouyang, Wenbin Chen: 25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4. Am J Cancer Res 2019;9(10):2140-2155. (Full text, PDF)
Xinyuan Zhao, Li Cui: Development and validation of a m6A RNA methylation regulators-based signature for predicting the prognosis of head and neck squamous cell carcinoma. Am J Cancer Res 2019;9(10):2156-2169. (Full text, PDF)
Hui Guo, Weimin Kong, Lu Zhang, Jianjun Han, Leslie H Clark, Yajie Yin, Ziwei Fang, Wenchuan Sun, Jiandong Wang, Timothy P Gilliam, Douglas Lee, Liza Makowski, Chunxiao Zhou, Victoria L Bae-Jump: Reversal of obesity-driven aggressiveness of endometrial cancer by metformin. Am J Cancer Res 2019;9(10):2170-2193. (Full text, PDF, Supplementary File)
Shui-Zhen Shi, Eun-Joon Lee, Ying-Jiong Lin, Lu Chen, Huai-Yu Zheng, Xiang-Qin He, Jing-Yi Peng, Satish K Noonepalle, Austin Y Shull, Felix C Pei, Li-Bin Deng, Xiao-Li Tian, Ke-Yu Deng, Huidong Shi, Hong-Bo Xin: Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer. Am J Cancer Res 2019;9(10):2194-2208. (Full text, PDF)
Vladimir Subbotin, Gennady Fiksel: Modeling multi-needle injection into solid tumor. Am J Cancer Res 2019;9(10):2209-2215. (Full text, PDF)
Ronggao Chen, Yiting Qiao, Wendi Hu, Qiyang Cheng, Haiyang Xie, Lin Zhou, Xiao Xu, Shusen Zheng, Donghai Jiang: LY2228820 induces synergistic anti-cancer effects with anti-microtubule chemotherapeutic agents independent of P-glycoprotein in multidrug resistant cancer cells. Am J Cancer Res 2019;9(10):2216-2232. (Full text, PDF)
Shuyao Zhang, Hong Jiang, Zhe Xu, Yi Jiang, Yuqi She, Xiaoting Huang, Shanna Feng, Wanying Chen, Shuang Chen, Yun Chen, Guodong Qiu, Shilong Zhong: The resistance of esophageal cancer cells to paclitaxel can be reduced by the knockdown of long noncoding RNA DDX11-AS1 through TAF1/TOP2A inhibition. Am J Cancer Res 2019;9(10):2233-2248. (Full text, PDF)
Zhen-Hua Wu, Chen-Chen Liu, Yu-Qiang Zhou, Li-Na Hu, Wei-Jian Guo: OnclncRNA-626 promotes malignancy of gastric cancer via inactivated the p53 pathway through interacting with SRSF1. Am J Cancer Res 2019;9(10):2249-2263. (Full text, PDF, Supplementary Data 1, 2, 3)
Xin He, Fan Meng, Lingyu Qin, Zhile Liu, Xiongjie Zhu, Zhongjian Yu, Yanfang Zheng: KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma. Am J Cancer Res 2019;9(10):2264-2277. (Full text, PDF)
Retraction: Long noncoding RNA GAS5 inhibits metastasis by targeting miR-182/ANGPTL1 in hepatocellular carcinoma. Am J Cancer Res 2019;9(10):2278. (Full text, PDF)
Retraction: Long noncoding RNA CASC11 promotes osteosarcoma metastasis by suppressing degradation of snail mRNA. Am J Cancer Res 2019;9(10):2279. (Full text, PDF)
